NCT01430611View on ClinicalTrials.gov

Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

666

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

November 30, 2012

Conditions
Meningococcal DiseaseMeningitis
Interventions
BIOLOGICAL

Meningococcal (Groups A and C) Polysaccharide Vaccine

0.5 mL, Subcutaneous

BIOLOGICAL

Meningococcal (Groups A and C) Polysaccharide Vaccine

0.5 mL, Subcutaneous

Trial Locations (2)

210009

Nanjing

223200

Chuzhou

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01430611 - Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children | Biotech Hunter | Biotech Hunter